14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ASND ranks #16854 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Ascendis Pharma A/S Stock Forecast NASDAQ:ASND

$135.61 (-7.05%)

Volume: 401k

Closed: Dec 03, 2021

Hollow Logo Score: -6.374

Ascendis Pharma A/S Stock Forecast

$135.61 (-7.05%)

Volume: 401k

Closed: Dec 03, 2021

Score Hollow Logo -6.374
Which way will ASND go? Request
Key Stats
Beta 0.36
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 32 and the stock is currently not being overbought or oversold

Ascendis Pharma A/S stock price took a fall of -7.05% on Friday
(Updated on Dec 03, 2021)

Sell candidate since 2021-11-10 Loss -11.40%

The Ascendis Pharma A/S stock price fell by -7.05% on the last day (Friday, 3rd Dec 2021) from $145.89 to $135.61. During the day the stock fluctuated 9.50% from a day low at $133.05 to a day high of $145.69. The price has fallen in 6 of the last 10 days and is down by -8.77% for this period. Volume has increased on the last day by 236 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 401 thousand shares were bought and sold for approximately $54.42 million.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $132.34 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -9.70% during the next 3 months and, with a 90% probability hold a price between $119.50 and $142.93 at the end of this 3-month period.

Signals & Forecast

There are few to no technical positive signals at the moment. The Ascendis Pharma A/S stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $141.79 and $150.57. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, November 02, 2021, and so far it has fallen -17.47%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $12.65 between high and low, or 9.50%. For the last week, the stock has had a daily average volatility of 6.13%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Ascendis Pharma A/S stock A Buy?

Ascendis Pharma A/S holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -6.374

Predicted Opening Price for Ascendis Pharma A/S of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$138.12 $135.61 (Undervalued)
Strong Sell Candidate Downgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 15, 2021 "SVB Leerink" gave "$182.00 - $190.00" rating for ASND. The price target was set to $157.81+1.3%.

Volatility and Risk
Daily Average Volatility: 6.13 %
Overall Risk: Very High High Medium Low Very Low
6.13 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $140.74
Price: $135.61
No Support Found

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 150.76 11.17 %
145.93 7.61 %
142.95 5.41 %
Current price: 135.61
Support 133.28 -1.71 %
130.30 -3.92 %
125.47 -7.48 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 146.93 8.35 %
145.62 7.38 %
140.74 3.78 %
Current price 135.61
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a clinical stage biopharmaceutical company, develops various prodrug therapies to treat unmet medical needs. It is developing TransCon human growth hormone that has completed Phase II clinical trials in children and adults to treat growth hormone deficiency (GHD) and other indications; and TransCon Treprostinil that has completed Phase I clinical trial for the treatment of pulmonary arterial hypertension, a life-threatening d... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE